Herskovitz Elissa, Solomides Charalamobos, Barta Julie, Evans Nathaniel, Kane Gregory
Thomas Jefferson University Hospitals, United States.
Thomas Jefferson University Hospitals, United States.
Respir Med. 2022 May;196:106803. doi: 10.1016/j.rmed.2022.106803. Epub 2022 Mar 12.
Pure ground glass opacities (GGO) may indicate pre-invasive subtypes of lung carcinoma. These neoplasms typically demonstrate indolent patterns of growth; Fleischner Society guidelines recommend up to five years of serial imaging. Our aim was to determine the frequency of diagnosed carcinoma arising from GGO detected beyond 5 years of surveillance. We reviewed pathologic diagnoses of lung carcinoma (n = 442) between 2016 and 2018 of a tertiary academic hospital and National Cancer Institute-designated cancer center to identify all cancers that arose from ground glass opacities detected on CT scan. Of the 442 cases of lung carcinoma, 32 (7%) were found that arose from pure GGOs and were ultimately diagnosed as cancer. Among the subgroup of GGOs, 78% (n = 25) were diagnosed within five years of surveillance, but up to 22% (n = 7) required between five and twelve years of serial follow up prior to definitive diagnosis. In order to detect 95% of cancers, GGOs would need to be followed for 7.9-12.7 years based upon a Kaplan-Meier estimate (p = 0.05). No patients who had lung carcinoma arising from GGOs died (0/32) within a follow-up time of one to three years. These data suggest that a greater number of lung carcinomas would be detected upon routine follow up of GGOs that extended beyond the current recommendation of five years. The overall survival of the cohort was 100%, consistent with existing data that these cancers are indolent. It is unknown whether a higher detection rate from longer interval follow up would impact overall survival.
纯磨玻璃影(GGO)可能提示肺癌的浸润前亚型。这些肿瘤通常表现为惰性生长模式;弗莱施纳学会指南建议进行长达五年的系列影像学检查。我们的目的是确定在超过5年的监测期后检测到的GGO所引发的确诊肺癌的发生率。我们回顾了一家三级学术医院和美国国立癌症研究所指定的癌症中心在2016年至2018年间肺癌(n = 442)的病理诊断,以识别所有源自CT扫描检测到的磨玻璃影的癌症。在442例肺癌病例中,发现32例(7%)源自纯GGO并最终被诊断为癌症。在GGO亚组中,78%(n = 25)在监测的五年内被诊断出来,但高达22%(n = 7)在最终诊断前需要进行5至12年的系列随访。根据Kaplan-Meier估计,为了检测到95%的癌症,GGO需要随访7.9至12.7年(p = 0.05)。在1至3年的随访期内,没有因GGO引发肺癌的患者死亡(0/32)。这些数据表明,对GGO进行超过目前推荐的五年的常规随访将检测到更多的肺癌。该队列的总生存率为100%,与这些癌症为惰性癌症的现有数据一致。更长间隔随访的更高检出率是否会影响总生存率尚不清楚。